Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Vittoria Biotherapeutics has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
Vittoria Biotherapeutics's investors include SV Health Investors, Agent Capital, BioAdvance, University of Pennsylvania, NYBC Ventures.
Vittoria Biotherapeutics is headquartered in Philadelphia, United States.
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Vittoria Biotherapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vittoria Biotherapeutics — Funding & Investors." VCBacked, November 13, 2023, https://www.vcbacked.co/company/vittoria-biotherapeutics. Accessed September 29, 2026.
VCBacked. (2023). Vittoria Biotherapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/vittoria-biotherapeutics
{{cite web |title=Vittoria Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vittoria-biotherapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated